2.8. Immunoblotting. Protein levels of p65, p50, PPAR-, and Gapdh of MNC were detected by western blotting with Santa Cruz antibodies against the p65 subunit (sc-372), p50 subunit (sc-114), PPAR-(sc-7273), and Gapdh (SC-48166) as described previously [24, 25] . Mononuclear cells were lysed in RIPA buffer (Cybrdi, Gaithersburg, MD, USA) that contained protease inhibitor (Roche Diagnostics, Indianapolis, IN, USA). Equal amounts of protein were loaded onto 4-12% Bis-Tris precast gels for electrophoresis and were electrotransferred onto a PVDF membrane (Roche Diagnostics). After blocking for 1 h at room temperature, membranes were sequentially incubated with primary Abs at 4 ∘ C overnight and secondary Abs at room temperature for 1 h. The protein signal was detected by chemiluminescence and all values were corrected by loading with Gapdh.
Immunoprecipitation.
Immunoprecipitation assays were performed as described previously [25, 26] . Cell extracts were prepared by using modified RIPA buffer (Cell Signaling Technology). Cell lysates (300 g) were incubated with 1 g of PPAR Ab (sc-7273) at 4 ∘ C overnight and precipitated with protein G agarose beads (Santa Cruz) at 4 ∘ C for 2 h. Immunoprecipitated proteins were separated by SDS-PAGE and transferred onto a PVDF membrane. Membranes were then sequentially incubated with primary ubiquitination Ab (SC-8017) and secondary Abs. Bands were visualized by using an ECL system. In addition, the below part should be added to the Discussion section after the third paragraph:
"The peroxisome proliferator-activated receptor-(PPAR-) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors which regulate adipocyte differentiation, glucose homeostasis, and macrophage activation [27] . PPAR-ubiquitination and degradation have been found in adipocyte, and proteasome inhibitors inhibited the downregulation of PPAR- [28] . Proinflammation cytokine was also found to induce PPARdegradation [29] . Herein, we found a novel mechanism such that PIO enhances PPAR-binding activity though inhibiting its ubiquitination and degradation, which may be important for TZDs clinical use."
Moreover, the references below should be included in the References list: 
